StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Citius Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Citius Pharmaceuticals's price to book ratio was 0.2× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.1× to 2.1×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.0
2025Dec 31, 20250.2×−0.2
2024Dec 31, 20240.4×−0.9
2023Dec 29, 20231.3×+0.2
2022Dec 30, 20221.1×−0.6
2021Dec 31, 20211.7×+0.0
2020Dec 31, 20201.7×+0.6
2019Dec 31, 20191.1×+0.5
2018Dec 31, 20180.5×−0.9
2017Dec 29, 20171.4×−0.5
2016Dec 30, 20161.9×–

More Citius Pharmaceuticals figures

See a number that looks wrong?